These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32600709)

  • 21. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
    Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS
    Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trans-[Ru(PPh
    Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
    J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
    Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
    J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the potential of ruthenium(II)-phosphine-mercapto complexes as new anticancer agents.
    Palmeira-Mello MV; Costa AR; de Oliveira LP; Blacque O; Gasser G; Batista AA
    Dalton Trans; 2024 Jul; 53(26):10947-10960. PubMed ID: 38895770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands.
    de Oliveira TD; Ribeiro GH; Honorato J; Leite CM; Santos ACDS; Silva ED; Pereira VRA; Plutín AM; Cominetti MR; Castellano EE; Batista AA
    J Inorg Biochem; 2022 Sep; 234():111906. PubMed ID: 35759891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the cytotoxic activity of Pd(II) complexes of N,N-disubstituted-N'-acyl thioureas.
    Plutín AM; Mocelo R; Alvarez A; Ramos R; Castellano EE; Cominetti MR; Graminha AE; Ferreira AG; Batista AA
    J Inorg Biochem; 2014 May; 134():76-82. PubMed ID: 24561278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
    De Grandis RA; Santos PWDSD; Oliveira KM; Machado ART; Aissa AF; Batista AA; Antunes LMG; Pavan FR
    Bioorg Chem; 2019 Apr; 85():455-468. PubMed ID: 30776556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies.
    Teixeira TM; Arraes IG; Abreu DC; Oliveira KM; Correa RS; Batista AA; Braunbeck T; de Paula Silveira Lacerda E
    Eur J Med Chem; 2021 Apr; 216():113262. PubMed ID: 33711764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
    do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
    J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes.
    Dos Santos ER; Graminha AE; Schultz MS; Correia I; Selistre-de-Araújo HS; Corrêa RS; Ellena J; Lacerda EPS; Pessoa JC; Batista AA
    J Inorg Biochem; 2018 May; 182():48-60. PubMed ID: 29433005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
    Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
    J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ru/Fe bimetallic complexes: Synthesis, characterization, cytotoxicity and study of their interactions with DNA/HSA and human topoisomerase IB.
    Takarada JE; Guedes APM; Correa RS; Silveira-Lacerda EP; Castelli S; Iacovelli F; Deflon VM; Batista AA; Desideri A
    Arch Biochem Biophys; 2017 Dec; 636():28-41. PubMed ID: 29107586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
    da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
    Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New copper(I) and heteronuclear copper(I)-ruthenium(II) complexes: Synthesis, structural characterization and cytotoxicity.
    Lopes J; Alves D; Morais TS; Costa PJ; Piedade MF; Marques F; Villa de Brito MJ; Helena Garcia M
    J Inorg Biochem; 2017 Apr; 169():68-78. PubMed ID: 28142080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis.
    Oliveira KM; Liany LD; Corrêa RS; Deflon VM; Cominetti MR; Batista AA
    J Inorg Biochem; 2017 Nov; 176():66-76. PubMed ID: 28865744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.